Methods Development
Altaris Unites WuXi and Minaris Assets to Launch Minaris Advanced Therapies as Global Cell Therapy CDMO Powerhouse
Through strategic acquisitions made by New York–based investment firm Altaris, Minaris Regenerative Medicine and the U.S. and U.K. operations of WuXi...
May 08, 2025 | News
Genezen to Manufacture Lentiviral Vector for Optieum’s CAR-T Therapy Targeting Glioblastoma
Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Optieum Biotechnologies, Inc. (Optieum), a preclinical stag...
May 06, 2025 | News
PCI Pharma Services Acquires Ajinomoto Althea’s Altair to Build Global Powerhouse in Aseptic Filling and Advanced Drug Delivery
PCI Pharma Services ("PCI") is pleased to announce the launch of Ajinomoto Althea, the world's leading contract research and manufacturing organi...
May 05, 2025 | News
Porton Advanced Supports IND Approval of Tasly’s Dual-Targeting CAR-T Therapy for Recurrent Glioblastoma
Porton Advanced proudly announces its CDMO support for Tasly Pharmaceutical Co., Ltd.'s innovative CAR-T therapy, "P134 Cell Injection," which has received...
April 17, 2025 | News
Rege Nephro Acquires Tamibarotene Assets from Syros Pharmaceuticals to Advance ADPKD Program
Rege Nephro Co., Ltd. (Headquarter: Kyoto, Japan; Chief Executive Officer: Akifumi Morinaka) has announced that it has successfully acquired Tami...
April 16, 2025 | News
TCI Biotech Elevates CDMO+ Services with US-Based Glass Bottling for Liquid Supplements
TCI Biotech (TCI Co., Ltd.), a CDMO+ organization specializing in health and wellness products, is spotlighting its comprehensive US-based glass bottling s...
April 03, 2025 | News
SHL Medical Launches $220M Autoinjector Facility in South Carolina to Boost US Production and Global Supply
SHL Medical, a global leader in the design, development, and manufacturing of advanced self-injection solutions, has officially inaugurated its new state-o...
April 02, 2025 | News
Langhua Pharmaceutical Receives FDA EIR Following Successful cGMP Inspection for the Fourth Time
Zhejiang Langhua Pharmaceutical Co., Ltd. ("Langhua Pharmaceutical"), a wholly-owned subsidiary of Viva Biotech Holdings ("Viva Biotech"), underwent a cGMP...
March 31, 2025 | News
Thermo Fisher Introduces Vulcan™ Automated Lab to Advance Semiconductor Process Development
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced the launch of the Thermo...
March 19, 2025 | News
WuXi Biologics Introduces EffiX™ a High-Yield E. coli Expression Platform for Recombinant Proteins and Plasmid DNA Production
EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. ...
March 04, 2025 | News
Chime Biologics and Mabgeek Advance MG-K10 to U.S. Phase III Trials for Atopic Dermatitis and Asthma
Chime Biologics, a leading global CDMO that enables its partners' success in biologics, announced its continued collaboration with Mabgeek ...
February 24, 2025 | News
LG Chem Begins Prototype Production of 100% Bio-Acrylic Acid in South Korea
LG Chem has launched prototype production of 100% bio-acrylic acid, which has received USDA Certified Biobased Product (BIOPREFERRED®) label. The pr...
February 13, 2025 | News
Wellumio’s Portable MRI ‘Axana’ Begins First Clinical Study in Australia for Rapid Stroke Detection
Wellumio, a New Zealand-based medical device company pioneering advancements in stroke detection, today announced enrollment of the first patien...
February 07, 2025 | News
Eleva and 3PBIOVIAN Forge Strategic Alliance to Advance Clinical-Grade Biologics Production
3PBIOVIAN provides production capacity for clinical-grade material for current and future development programs including Eleva’s proprietary Factor...
February 05, 2025 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
